Nixon Gwilt Law

NOVEMBER 17, 2022

As part of its ongoing effort to expand access to evidence-based treatments for acute and chronic pain and to improve the care experience for individuals suffering from pain, CMS introduced new CPT codes for Chronic Pain Management (“CPM”) services in the 2023 Medicare Physician Fee Schedule Final Rule (the “2023 MPFS”).

Physicians 52

Physicians Management Patients Medical 52

European Pharmaceutical Review

OCTOBER 19, 2023

These findings presented at the 2023 European AIDS Conference (EACS 2023) were based on the ongoing Bictegravir Single Tablet Regimen (BICSTaR) study. First paediatric EC approval of HIV drug The post EACS 2023: Gilead shares real-world evidence for Biktarvy® appeared first on European Pharmaceutical Review.

Safety 104

Safety Physicians Food Medical 104

PM360

DECEMBER 14, 2023

Survey any physician if they’ve been asked by a patient about a prescription weight loss medication and you’ll hear a resounding “yes.” The recent Sermo Barometer confirms that 89% of 300+ global practitioners have seen an increase in patients proactively requesting prescription weight loss medications.

Medical 105

Medical Side effects Physicians Prescription 105

Pharmaceutical Technology

DECEMBER 4, 2022

Indeed, Amgen’s biosimilar was approved in September 2016, but the company was not able to launch it until January 2023 in the US. In September 2017, Amgen announced that it reached a global settlement with AbbVie, scheduling Amjevita’s American launch for January 31, 2023. Product variation creates patient uncertainty.

Marketing 104

Marketing Physicians Competition Patients 104

PM360

JULY 13, 2023

PM360 asked experts in helping patients stay on their prescribed therapies about where the industry could make the biggest improvements and how to better detect potential barriers. How can the industry better monitor and detect potential barriers to adherence for individual patients? How can they improve?

Medical 98

Medical Patients Education Transportation 98

PM360

JULY 26, 2023

is facing an aging population, a mounting physician shortage, and increasing demands for a more equitable healthcare system. 2 It’s no wonder physicians across the country are limiting time with the industry and prioritizing their limited time with their patients. Patients are also seeing significant value in telemedicine.

Healthcare 98

Healthcare Healthcare Physicians Doctors 98

Nixon Gwilt Law

JULY 11, 2022

Every summer when the Centers for Medicare and Medicaid Services (“CMS”) releases the Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Nixon Gwilt Law (“NGL”) team excitedly opens the two-thousand-something-page PDF and immediately keys “ctrl+F” (or command+F for us Mac users) to jump to our most anticipated section(s).

Physicians 52

Physicians Management Healthcare Provider Patients 52

PM360

MARCH 24, 2023

In 2022, SXSW was all NFTs and metaverse activations and events, and in 2023 they weren’t anywhere to be found. Their website states: “In the AnchoringVR scenario patients select or create visual expressions of that experience and fuel them with audio recordings of their insights,” explains [Enosis co-founder Agnieszka] Sekula.

Media 119

Media Engineering Healthcare Healthcare 119

Legacy MEDSearch

DECEMBER 21, 2022

a groundbreaking respiratory support technology company, announced today that it has begun the manufacturing process for the ALICE CPB (Cardiopulmonary Bypass) device (the “ALICE device”) to undergo the Verification and Validation phase prior to its planned 2023 submission to the U.S. Press Release by: Inspira Technologies.

Manufacturing 98

Manufacturing FDA Food and Drug Administration Medical 98

Nixon Gwilt Law

NOVEMBER 7, 2022

Below is an overview of what will change in 2023, for better and for worse. Below is an overview of what will change in 2023, for better and for worse. ” — CMS.

Physicians 52

Physicians Management Medical Medicine 52

Nixon Gwilt Law

JULY 26, 2022

The much-anticipated 2023 Medicare Physician Fee Schedule Proposed Rule is here, and we covered everything you need to know in a one-hour webinar! How to Influence the Final Rule.

Physicians 52

Physicians Healthcare Provider Management Healthcare 52

Legacy MEDSearch

DECEMBER 19, 2022

Chairman, Dave Ferrera, announced treatment of the first patients in North America with the BossStent® device designed to treat patients with symptomatic cerebral venous diseases. Both the EU and FDA clinical trials will be initiated in Q2 2023 for the purpose of obtaining European and US regulatory approvals respectively in Q1 2024.

Patients 98

Patients Recruitment Physicians Management 98

InCrowd

NOVEMBER 1, 2023

Prescriber Perceptions around CRISPR in 2023 Four years ago, InCrowd assessed the awareness among physicians of nucleic acid-based therapies, their mechanisms of action, and their current and future promise. Download the report today. The post Instant Insights – CRISPR appeared first on InCrowd.

Physicians 100

Physicians Healthcare Healthcare Patients 100

PM360

AUGUST 24, 2023

biosimilars market is evolving rapidly and pharma marketing programs need to evolve as well to better meet physician needs. healthcare system but we haven’t seen widespread acceptance by doctors and patients. But how can biosimilar brands most effectively support providers and patients throughout the care journey?

Marketing 97

Marketing Physicians Electronics Patients 97

Nixon Gwilt Law

JULY 8, 2022

The much-anticipated 2023 Medicare Physician Fee Schedule Proposed Rule (“2023 Proposed Rule”) from the Centers for Medicare & Medicaid Services (“CMS”) has arrived! More detailed analyses from the Nixon Gwilt Law team will follow, but in the meantime, here are our top takeaways from the 2023 Proposed Rule.

Physicians 52

Physicians Management Patients Medical 52

PM360

NOVEMBER 2, 2023

Nuvera Life Science Consulting is pleased to announce its third annual awards for the pharmaceutical companies designated as “best-in-class” in patient support and access by physicians and support staff surveyed for the company’s 2023 PURE Reports : Bristol Myers Squibb in oncology and Genentech in neurology.

Pharmaceutical 52

Pharmaceutical Patients Physicians Consulting 52

Nixon Gwilt Law

AUGUST 2, 2022

Specifically, the Proposed Rule would add several services to the Medicare Telehealth List (most on a temporary basis through the end of 2023) and adjust the use of modifiers when submitting telehealth claims following the end of the PHE. Should CMS extend the coverage of Category 3 services beyond 2023?

Physicians 52

Physicians Training Education Patients 52

PM360

APRIL 7, 2023

Reduced patient out-of-pocket (OOP) costs in Part D have the potential to reduce beneficiary reliance on foundation support, with commensurate reductions in manufacturer donations required. The business-to-business market leaders must find new and creative ways to help patients receive their treatments. The 340B battle will rage on.

Manufacturing 97

Manufacturing Insurance Marketing Government 97

Clarify Health

JUNE 13, 2023

At-risk program for health plans is fully managed by Clarify Health San Francisco, CA (June 13, 2023) – Clarify Health , a leading healthcare analytics and value-based payments platform company, is pleased to announce its newest program to improve specialist referrals delivered through its Clarify Advance solution.

Physicians 52

Physicians Healthcare Healthcare Management 52

PM360

MAY 15, 2023

As healthcare champions, we embrace the power of patient education. Education is empowering and transformative— when patients read it. If patients read it. This can be disheartening for those of us dedicated to writing and designing impactful and engaging patient education. But do providers utilize patient education?

Education 81

Education Patients Pharma Doctors 81

European Pharmaceutical Review

NOVEMBER 7, 2023

The treatment is being evaluated in patients with upper GI adenocarcinomas. Gilead shared that in the trial, the six-month landmark PFS rate was 93 percent for patients with PD-L1-high tumours, 68 percent for patients with PD-L1-low tumours and 77 percent for patients overall.

Safety 114

Safety Patients Physicians Medical 114

PM360

APRIL 7, 2023

Patient Pages: How Healthcare Costs Affect Insured Patients Today A new study shows an insured American with an employer-sponsored health insurance plan can expect to spend more than $320,000 (including insurance premiums and out-of-pocket costs) during his/her adult lifetime.

Healthcare 52

Healthcare Healthcare Insurance Physicians 52

Nixon Gwilt Law

MAY 26, 2023

Providers are already integrating Virtual Reality ( VR ) into patient care in a variety of ways. So, how do patients get access to this technology, and how do providers get paid for using it? Reimbursement impacts patient access, business and revenue models, investment potential, and product development. More on that later.

Healthcare 119

Healthcare Healthcare Marketing Healthcare Provider 119

PM360

MAY 15, 2023

Karina Castagna SVP Access and Adherence OptimizeRx Advancing Digital Access at Point-of-Care Karina Castagna believes every life sciences company must have digital omnichannel as a key pillar in its marketing and access strategy for point of care (POC) and point of prescribe to better serve both providers and patients.

Physicians 59

Physicians Electronics Manufacturing Prescription 59

Nixon Gwilt Law

JULY 20, 2023

When the COVID-19 Declaration of a Public Health Emergency (the “PHE”) ended on May 11, 2023, we saw Congress extend some telehealth flexibilities introduced during the PHE and curtail others. The 2023 CAA further extended these flexibilities through the end of 2024.

Physicians 52

Physicians Patients Consulting Management 52

PM360

MAY 15, 2023

As Pharming prepared to launch the first treatment for APDS, they needed to get creative to find and educate potential patients as well as the physicians who may be treating them. To develop their approach for reaching physicians, Pharming partnered with PRECISIONscientia to utilize their DOL Map.

Healthcare 59

Healthcare Healthcare Physicians Media 59

Clarivate

APRIL 24, 2023

Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients. In January 2023, VillageMD acquired Summit Health for $8.9

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

European Pharmaceutical Review

SEPTEMBER 28, 2023

This evaluated 162 patients randomised at Week 6 to receive either ENTYVIO SC 108mg or placebo by subcutaneous injection every two weeks. Data showed that at at Week 52, 46 percent of patients who were given the biologic maintenance therapy achieved clinical remission.

Food and Drug Administration 104

Food and Drug Administration FDA Physicians Food 104

InCrowd

DECEMBER 12, 2023

In December of 2023, InCrowd surveyed 105 US attending Physicians and Residents to explore the possibility of implementing AI into Healthcare settings. InCrowd surveyed US attending Physicians and Residents to gauge their attitude regarding the emerging trend of AI being implemented into their practice.

Healthcare 100

Healthcare Healthcare Physicians Patients 100

Nixon Gwilt Law

JULY 23, 2024

In the recently released 2025 Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Centers for Medicare & Medicaid Services (CMS) created a new reimbursement pathway for “Digital Mental Health Treatment” (DMHT) devices and services. for conditions other than substance abuse disorder, insomnia, and depression)?

Physicians 52

Physicians FDA Safety Management 52

pharmaphorum

JULY 18, 2022

“There is a dire need to provide an alternative treatment option to these patients.” In the US, trastuzumab duocarmazine has been given an anticipated review date of 12 May 2023 by the FDA, a standard ten-month review time. The post Byondis cues up US, EU decisions on breast cancer ADC in 2023 appeared first on.

Side effects 59

Side effects Physicians FDA Marketing 59

PM360

APRIL 7, 2023

At its heart, the point of care has always revolved around the when and where patients are making decisions about their health. But now patients can also see an HCP via telehealth or chat with them through an online patient portal. Put yourself in the shoes of your patients. Understand how precise you can get.

Doctors 98

Doctors Education Patients Physicians 98

European Pharmaceutical Review

DECEMBER 6, 2023

The first, the Phase III APPLY-PNH trial evaluated patients with residual anaemia (haemoglobin < 10 g/dL) despite prior anti-C5 treatment who switched to Fabhalta. percent of anti-C5-experienced Fabhalta patients responded versus 0 percent for anti-C5. Patients avoiding transfusion: The transfusion avoidance rate was 95.2

Food and Drug Administration 108

Food and Drug Administration Patients Physicians Food 108

Legacy MEDSearch

MAY 1, 2023

The results were featured in the late-breaking session ( LBA01-05 ) at the American Urological Association (AUA) 2023 Annual Meeting in Chicago on Sunday, April 30 th. Moreover, the patient-centric nature of the therapy that facilitates individually tailored treatment, resulted in an increasing improvement in UUI over time with 91.6%

Patients 52

Patients Medical Safety Recruitment 52

pharmaphorum

JUNE 30, 2022

At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow research and development (R&D) stakeholders, regulators, health and digital data partners and more to navigate challenges in drug development that impact patients globally. Patient journey. Patient access.

Patients 64

Patients Recruitment Transportation Healthcare 64

Nixon Gwilt Law

JULY 23, 2024

In the recently released 2025 Medicare Physician Fee Schedule Proposed Rule (the “Proposed Rule”), the Centers for Medicare & Medicaid Services (CMS) created a new reimbursement pathway for “Digital Mental Health Treatment” (DMHT) devices and services. for conditions other than substance abuse disorder, insomnia, and depression)?

Physicians 52

Physicians FDA Safety Management 52

European Pharmaceutical Review

JANUARY 13, 2023

AstraZeneca’s Tezspire (tezepelumab) has received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for self-administration in a pre-filled, single-use auto-injector (AI) pen for severe asthma patients over 12 years. Trial results on the biologic for severe asthma . Regulatory decisions for Tezspire.

Food and Drug Administration 98

Food and Drug Administration Medicine FDA Physicians 98